Anti-shock injection to improve combat casualty care

Active Purchase Order Awarded Last action

Contract number
FA864925P0362
Awardee
Awarding agency
Obligated
$1,245,837

Award facts

Contract value 100% obligated
$1,245,837.00 Current and potential, with all options
Completion date 85% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 115 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Arlington, MD 21215, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 $0
Supplemental Agreement for work within scope P00001 $0
Original award $1,245,837

About this award

The Air Force Research Laboratory awarded a purchase order to NKA Bio, Inc. for anti-shock injection technology to improve combat casualty care, with a ceiling value of $1,245,837 and an award date of July 15, 2025. The order carries a Total Small Business set-aside. Performance occurs in Arlington, Maryland, with an ultimate completion date of January 15, 2027. Pricing is firm fixed price.

Quick answers

Who was awarded contract FA864925P0362?

FA864925P0362 was awarded to NKA Bio, Inc. by Air Force Research Laboratory (Air Force Materiel Command) on July 15, 2025.

How much is contract FA864925P0362 worth?

The government has obligated $1,245,837 on FA864925P0362.

Was contract FA864925P0362 competed?

The extent of competition for FA864925P0362 was full and open competition after exclusion of sources. The government received 115 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award